Home/Filings/4/0001104659-20-050692
4//SEC Filing

Orlinger Klaus 4

Accession 0001104659-20-050692

CIK 0001760542other

Filed

Apr 23, 8:00 PM ET

Accepted

Apr 24, 8:55 AM ET

Size

5.3 KB

Accession

0001104659-20-050692

Insider Transaction Report

Form 4
Period: 2020-04-20
Orlinger Klaus
Sr. VP, Research
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-04-20+30,0000 total
    Exercise: $8.03Exp: 2030-04-20Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest on February 15, 2021, with the remainder vesting in 12 equal quarterly installments thereafter.

Documents

1 file

Issuer

HOOKIPA Pharma Inc.

CIK 0001760542

Entity typeother

Related Parties

1
  • filerCIK 0001768432

Filing Metadata

Form type
4
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 8:55 AM ET
Size
5.3 KB